ArticlePharmaceuticals (Basel, Switzerland)2023

Molnupiravir, Nirmatrelvir/Ritonavir, or Sotrovimab for High-Risk COVID-19 Patients Infected by the Omicron Variant: Hospitalization, Mortality, and Time until Negative Swab Test in Real Life.

Luca Cegolon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.